Mumbai, May 7 (IANS) Dr Reddy’s Laboratories on Tuesday reported a 36 per cent jump in net profit at Rs 1,307 crore for the Jan-March quarter of 2023-24 compared to the corresponding figure of Rs 960 crore in the same period of the previous year.
The Hyderabad-based pharma major posted a 12 per cent increase in total revenue at Rs 7083 crore, compared to Rs 6,297 crore in the fourth quarter of the previous year.
Dr Reddy’s board declared a final dividend of Rs 40 per share (800 per cent) of Rs 5 each for the financial year 2023-24, the company said in a stock exchange filing.
At the operating level, EBITDA rose 14 per cent to Rs 1872 crore as against Rs 1631.2 crore last fiscal. EBITDA margin stood at 26.4 per cent as compared to 25.9 per cent.
According to market analysts, the success of the blockbuster cancer drug Revlimid played a key role in driving up the company’s profit and revenue in the fourth quarter.
The company also said that Parag Agarwal will retire as the Chief Financial Officer of the Company effective from the close of working hours on July 31, 2024. M V Narasimham, the Deputy Chief Financial Officer of the Company is being elevated to the role of the Chief Financial Officer of the Company with effect from August 1, 2024.
–IANS
sps/dan
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
